|
|||||
|
|

Regional banking company First Citizens BancShares (NASDAQGS:FCNC.A) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 3.5% year on year to $2.37 billion. Its non-GAAP profit of $44.78 per share was 14.5% above analysts’ consensus estimates.
Is now the time to buy FCNCA? Find out in our full research report (it’s free).
First Citizens BancShares' second quarter results were met with a negative market reaction, reflecting concerns about declining sales and muted growth in key lending areas. Management cited the lowest net charge-offs since last year and disciplined expense control, but acknowledged that loan originations remained under pressure, particularly in technology and healthcare portfolios. CEO Frank Holding pointed to ongoing efforts to consolidate platforms and deepen client relationships, while CFO Craig Nix highlighted that sequential net interest income growth was primarily driven by a higher asset base and improved deposit costs. Nix described credit quality as stable, but warned that competition for new loans was fierce and that overall demand remains soft, especially in the branch network.
Looking ahead, management’s guidance is shaped by ongoing macroeconomic uncertainty, increased regulatory scrutiny, and persistent competitive pressures in both lending and deposit gathering. CFO Craig Nix signaled a cautious approach to loan growth, citing that, “we remain cautiously optimistic on absolute loan levels given lower growth in the first half of the year.” Nix also noted that expense growth will accelerate as investments in technology and risk management ramp up to meet Category 3 bank requirements. The company expects headwinds from a shifting interest rate environment, with Nix stating, “the fluidity of changes makes it difficult to narrow the range of potential impacts on the broader economy and on our business lines and clients.”
Management attributed the quarter’s underwhelming results to sluggish loan demand, competitive pricing, and continued pressure in the innovation economy, while highlighting progress in risk management and diversified revenue streams.
Looking ahead, management expects muted loan and deposit growth, expense pressures from regulatory readiness, and ongoing uncertainty from macroeconomic and industry-specific factors.
Going forward, our analysts will be watching (1) the pace of loan origination recovery, especially within technology and healthcare banking; (2) expense inflation as investments in risk management and technology accelerate for regulatory compliance; and (3) the success of deposit growth strategies in the face of ongoing industry competition. The performance of the rail and wealth management businesses, along with any shifts in the macroeconomic outlook, will also serve as key indicators for future results.
First Citizens BancShares currently trades at $1,883, down from $2,114 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-24 | |
| Oct-23 | |
| Oct-23 | |
| Oct-23 | |
| Oct-23 | |
| Oct-23 | |
| Oct-23 | |
| Oct-23 | |
| Oct-22 | |
| Oct-22 | |
| Oct-21 | |
| Oct-21 | |
| Oct-21 | |
| Oct-16 | |
| Oct-16 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite